BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Green Brick Partners
GRBK
$3.04B
| $60.5K | ﹤0.01% |
7,510
+1,727
| +30% | +$18.3K |
|
3302
Primis Financial Corp
FRST
$413M
| $60.3K | ﹤0.01% |
6,130
+1,348
| +28% | +$18.9K |
|
|
ECOM
3303
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $60K | ﹤0.01% |
8,267
+4,345
| +111% | +$38.2K |
|
|
CAMP
3304
DELISTED
CalAmp Corp.
CAMP
| $60K | ﹤0.01% |
580
+113
| +24% | +$22.1K |
|
|
TBNK
3305
DELISTED
Territorial Bancorp Inc.
TBNK
| $59.9K | ﹤0.01% |
2,441
+526
| +27% | +$14.5K |
|
3306
SmartFinancial
SMBK
$899M
| $59.9K | ﹤0.01% |
3,938
+881
| +29% | +$17.3K |
|
3307
First Capital
FCAP
$219M
| $59.7K | ﹤0.01% |
997
+244
| +32% | +$15.9K |
|
3308
Boston Omaha
BOC
$431M
| $59.7K | ﹤0.01% |
3,294
+1,435
| +77% | +$27.5K |
|
|
CBMG
3309
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $59.5K | ﹤0.01% |
3,758
+1,670
| +80% | +$27K |
|
3310
POSCO
PKX
$17.1B
| $59.4K | ﹤0.01% |
1,820
-145
| -7% | -$6.18K |
|
|
KDNY
3311
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $59.1K | ﹤0.01% |
4,313
+2,356
| +120% | +$27.9K |
|
|
EXTN
3312
DELISTED
Exterran Corporation
EXTN
| $58.9K | ﹤0.01% |
12,278
+1,040
| +9% | +$6.23K |
|
3313
Southern Missouri Bancorp
SMBC
$850M
| $58.9K | ﹤0.01% |
2,425
+614
| +34% | +$20.8K |
|
3314
Select Water Solutions
WTTR
$2.63B
| $58.7K | ﹤0.01% |
18,188
+5,177
| +40% | +$32.9K |
|
|
AVID
3315
DELISTED
Avid Technology Inc
AVID
| $58.7K | ﹤0.01% |
8,726
+4,195
| +93% | +$33.1K |
|
3316
Minerva Neurosciences
NERV
$187M
| $58.6K | ﹤0.01% |
1,217
+656
| +117% | +$39.6K |
|
3317
Oppenheimer Holdings
OPY
$1.23B
| $58.5K | ﹤0.01% |
2,961
+405
| +16% | +$9.89K |
|
3318
Metropolitan Bank Holding Corp
MCB
$1.17B
| $58.5K | ﹤0.01% |
2,171
+487
| +29% | +$20.3K |
|
3319
Home Bancorp
HBCP
$569M
| $58.4K | ﹤0.01% |
2,393
+512
| +27% | +$16.8K |
|
3320
Western Midstream Partners
WES
$20B
| $58.4K | ﹤0.01% |
18,031
-74,039
| -80% | -$1.02M |
|
|
GNTY
3321
DELISTED
Guaranty Bancshares
GNTY
| $58.3K | ﹤0.01% |
2,772
+613
| +28% | +$16.1K |
|
|
TUFN
3322
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $58.2K | ﹤0.01% |
+6,628
| New | +$82.8K |
|
3323
Ribbon Communications
RBBN
$377M
| $57.7K | ﹤0.01% |
19,041
+3,895
| +26% | +$11.7K |
|
|
MCBC
3324
DELISTED
Macatawa Bank Corp
MCBC
| $57.6K | ﹤0.01% |
8,086
+1,812
| +29% | +$17.5K |
|
3325
Greenlight Captial
GLRE
$512M
| $57.5K | ﹤0.01% |
9,669
+1,874
| +24% | +$16.1K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.